Ferring announces investment in Robyn, an online community that provides access to fertility and parental wellness resources


– Ferring Pharmaceuticals has finalized a two-year investment agreement including an option to acquire with Robyn. Together, Ferring and Robyn will provide expanded resources for people on the path to parenthood.

– The investment in Robyn reflects Ferring’s strategy of partnering with innovative start-ups focused on supporting people on their family-building journeys.

PARSIPPANY, NJ, February 15, 2022 /PRNewswire/ — Underscoring its commitment to empowering people looking to build families, Ferring Pharmaceuticals has entered into a two-year investment agreement that includes an option to acquire with Robyn, an online platform dedicated to supporting people building families. a family. A leader in reproductive medicine and maternal health, Ferring builds on its strengths in innovative science by investing in start-ups that promote community and patient empowerment.

(PRNewsphoto/Ferring Pharmaceuticals)

“As a leader in reproductive medicine, Ferring listens to and responds to the needs of the fertility community,” said brent ragansPresident, Ferring Pharmaceuticals US “We are proud to invest in Robyn because we share a mission to educate and support those looking to grow their families. Through this partnership and future investments, we will continue to expand our offerings for people who are starting families.

Ferring Pharmaceuticals is a driving force in amplifying the conversation about family building challenges and offering supportive solutions. In 2021, Ferring launched Fertility Out Loud, a platform and social community that provides resources and information for those struggling to start or grow a family. Ferring also offers Fertility House Calls, a nationally available platform that connects women and couples with fertility specialists for an initial consultation. These programs have given Ferring an even deeper understanding of the patient experience and this partnership with Robyn will focus on addressing unmet needs in the community.

“Since its inception, Robyn has been on a mission to support individuals on their journey to parenthood while improving parenting outcomes,” noted Allison KasirerCEO and Founder of Robyn. “Ferring Pharmaceuticals’ investment in our platform ensures access to the growing range of resources that our community relies on. Through this partnership, we are excited to expand our combined reach to meet the ever-changing needs of parents-to-be, future parents and new parents. “

Ferring and Robyn will share information about expanded resources for people on the path to parenthood later this year.

About Ferring Pharmaceuticals
Ferring Pharmaceuticals is a research-driven specialty biopharmaceutical group committed to helping people around the world build families and live better lives. In United States, Ferring is a leader in reproductive medicine and maternal health, as well as in specialty areas of gastroenterology and orthopedics. For more information, call 1-888-FERRING + (1-888-337-7464); visit http://www.ferringusa.com/

On Robyne
Robyn is a community-driven digital platform that provides access to a network of tools, resources and specialists in integrative parenting. By founding Robyn, Allison Kasirer made it her mission to make sure no other parent ever felt as alone and confused as she once did on her journey to parenthood. For more information visit https://wearerobyn.co/

For more information please contact

Ferring Pharmaceuticals
Patrick Gorman
Senior Director, Corporate Communications
(862) 286 5035 (direct)
(973) 722 6335 (mobile)
[email protected]


Evoke KYNE
Therese Dolge
Head of Media Relations
(215) 928-2748 (direct line)
(215) 317-7381 (cell)
[email protected]

Robin Logo

Robin Logo



View original content for multimedia download: https://www.prnewswire.com/news-releases/ferring-announces-investment-in-robyn-an-online-community-that-provides-access-to-fertility-and -parenting-wellness-resources-301481965.html

SOURCE Ferring Pharmaceuticals


About Author

Comments are closed.